Results for “”

Entry Author Date Location
Anthem Caps Coverage Of Biogen Spine Drug Despite Wide FDA Approval 01/24/17 Boston
Report: Biotech VCs Perpetuate Boardroom Gender Gap 01/24/17 National
Armed with $16M, Cue Biopharma Aims for Selective Immunotherapy 01/24/17 Boston
Ex-FDA Commish Califf Gives Props to Patient Groups—With Caveats 01/23/17 National
Turbonomic Grabs $50M More Amid Flurry of New England IT Deals 01/23/17 Boston
New Lexumo CEO on IoT, Startups & Government’s Role in Cybersecurity 01/23/17 Boston
Business Leaders Talk Trump’s Impact on Visas, Drug Pricing, Insurance 01/20/17 National
Dems Grill HHS Nominee Price About Trump Comments, Stock Holdings 01/18/17 National
HPE Scoops Up MA “Unicorn” SimpliVity for $650M, Ending IPO Talk 01/18/17 Boston
With Another Migraine Drug Bet, Lilly Snaps Up CoLucid For $960M 01/18/17 Indiana
Salsify Grabs $30M to Go Big in Product Content for Digital Retail 01/18/17 Boston
Hunting For Pharma Deals, Ovid Bags Epilepsy Drug from Takeda 01/18/17 New York
Biogen to Pay $1.25B to Settle Forward Pharma Patent Suit on MS Drug 01/17/17 Boston
Neurala, With More Cash, Advances A.I. for Drones, Self-Driving Cars 01/17/17 Boston
Notes From The JPM ’17 Vortex: Trump, Rainstorms & The Price You Pay 01/13/17 National
VC Activity in Boston Dipped in 2016; Here Are the Top 10 Deals & Exits 01/11/17 Boston
Biopharma Leaders Call for Gender Diversity Amid J.P. Morgan Conference 01/11/17 San Francisco
Vertex Deals Cancer Drugs to Merck KGaA for $230M, Following Plan 01/11/17 Boston
EzCater Gobbles $35M From Iconiq Capital, Insight Venture Partners 01/11/17 Boston
At Allergan And Other Pharmas, Price Transparency Has Limits 01/11/17 National
Mobile App Firm Apperian Sold to Arxan as Security Demand Grows 01/11/17 Boston
VC Activity Continues Slowdown in Fourth Quarter, and Top 10 Deals 01/11/17 National
CEO Kaye Details Insurance Battle As Sarepta Launches Duchenne Drug 01/10/17 Boston
Kaminario Snags $75M as Big Money Flows Into Flash Storage 01/10/17 Boston
Allergan, Eying More Neurodegenerative Drugs, Gets Right to Buy LTI 01/09/17 Boston
Takeda to Buy Ariad in $5.2B Move to Build Up Cancer Drug Portfolio 01/09/17 Boston
Indigo’s Microbial Treatment for Cotton Reaps Gains in Crop Yields 01/09/17 Boston
New Bain Investor Yumin Choi on Obamacare’s Future, Surviving Cancer 01/09/17 Boston
Merrimack Hits Reset Button, Sells Cancer Drugs to Ipsen For $575M 01/08/17 Boston
PatientsLikeMe Nabs $100M, Works to Advance Personalized Medicine 01/06/17 Boston
Page 1 of 81 next page »